Growth Metrics

Femasys (FEMY) Other Accumulated Expenses (2020 - 2026)

Femasys posted quarterly Other Accumulated Expenses of $29836.0 for Q1 2026, down 13.31% year-on-year from $34418.0 in Q1 2025, and down 53.61% on a QoQ basis from $64320.0 in Q4 2025.

Femasys (FEMY) has 7 years of Other Accumulated Expenses data on file, last reported at $29836.0 in Q1 2026.

  • For the quarter ending Q1 2026, Other Accumulated Expenses fell 13.31% year-over-year to $29836.0; the trailing twelve-month figure through Mar 2026 stood at $29836.0 (down 13.31% YoY), and the FY2025 full-year result was $64320.0, down 14.83% from the prior year.
  • Other Accumulated Expenses for Q1 2026 stood at $29836.0, down from $64320.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $104178.0 in Q3 2022 and bottomed at $7960.0 in Q3 2025.
  • The 5-year median for Other Accumulated Expenses is $53606.0 (2024), against an average of $51534.5.
  • The widest annual swing landed in 2023, when Other Accumulated Expenses plunged 89.23%; it then surged 473.03% in 2024.
  • A 5-year view of Other Accumulated Expenses shows it stood at $11197.0 in 2022, then climbed by 17.7% to $13179.0 in 2023, then soared by 473.03% to $75519.0 in 2024, then dropped by 14.83% to $64320.0 in 2025, then slumped by 53.61% to $29836.0 in 2026.
  • The last three Other Accumulated Expenses figures came in at $29836.0 (Q1 2026), $64320.0 (Q4 2025), and $7960.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Femasys 22.30 Mn 16.91 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 29,836.00
Dec 31, 2025 64,320.00
Sep 30, 2025 7,960.00
Jun 30, 2025 35,616.00
Mar 31, 2025 34,418.00
Dec 31, 2024 75,519.00
Sep 30, 2024 53,615.00
Jun 30, 2024 58,050.00
Mar 31, 2024 53,606.00
Dec 31, 2023 13,179.00
Sep 30, 2023 11,221.00
Jun 30, 2023 21,501.00
Mar 31, 2023 101,432.00
Dec 31, 2022 11,197.00
Sep 30, 2022 104,178.00
Jun 30, 2022 103,913.00
Mar 31, 2022 96,526.00
Dec 31, 2021 36,037.00
Sep 30, 2021 189,937.00
Jun 30, 2021 32,895.00
Dec 31, 2020 31,557.00